Haimov M, Burrows L, Schanzer H, Neff M, Baez A, Kwun K, Slifkin R
J Cardiovasc Surg (Torino). 1980 Mar-Apr;21(2):149-54.
Thirty autogenous saphenous vein grafts, 91 modified bovine heterografts and 96 PTFE grafts were used in the construction of vascular access for hemodialysis. The indication for the use of an arterial substitute was the unavailability of suitable artery or vein for the construction of a standard subcutaneous arteriovenous fistula. Ten of these grafts were placed in the lower extremity while the rest were placed in either the forearm or upper arm. All three types of grafts provided an immediate satisfactory solution to a difficult problem. When compared in terms of longterm patency, the autogenous saphenous vein proved to be inferior to either the modified bovine heterograft or the PTFE graft. Comparing all three grafts, the PTFE graft is currently our vascular substitute of choice for patients requiring grafts for arteriovenous fistulas for hemodialysis.
30条自体隐静脉移植物、91条改良牛异种移植物和96条聚四氟乙烯（PTFE）移植物被用于构建血液透析的血管通路。使用动脉替代物的指征是无法获得合适的动脉或静脉来构建标准的皮下动静脉内瘘。其中10条移植物置于下肢，其余的置于前臂或上臂。所有三种类型的移植物都为一个难题提供了即时的满意解决方案。就长期通畅率而言，自体隐静脉被证明不如改良牛异种移植物或PTFE移植物。比较这三种移植物，对于需要移植物来构建血液透析动静脉内瘘的患者，PTFE移植物目前是我们的血管替代物首选。
